Aptagen, LLC
TB-5 Nucleolin Aptamer (ID# 8587)
DNA
Nucleolin (NCL)
Protein
165.9 nM (reported value)
Dulbecco’s phosphate buffered saline with 4.5 g/L glucose, 5 mM MgCl2, 0.1 mg/mL yeast tRNA, 1 mg/mL BSA
4 °C°C
N/A
Recognizes Breast cancer (5637, SW780, MCF-7), Ovarian cancer (Ovcar3), Colon cancer (RKO), Lung cancer (A549), Liver cancer (HepG2). Low recognition of Renal cancer, Stomach cancer.
Does not form G-quadruplex secondary structure.
Appears to bind to RRM2 and RRM3.
5'-dTpdTpdTpdTpdTpdApdApdGpdCpdCpdCpdApdCpdTpdCpdCpdTpdCpdTpdGpdTpdGpdGpdGpdGpdGpdGpdCpdGpdApdApdCpdApdApdCpdApdApdGpdGpdCpdApdGpdTpdCpdGpdTpdGpdCpdCpdApdTpdGp
52
16020.4 g/mol
487700 L/(mole*cm)
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Y. Liu, B. Hu, X. Pei, J. Li, D. Qi, Y. Xu, H. Ou, Y. Wu, L. Xue, J. H. Huang, E. Wu, X. Hu, A Non-G-Quadruplex DNA Aptamer Targeting NCL for Diagnosis and Therapy in Bladder Cancer. Adv. Healthcare Mater. 2023, 12, 2300791. https://doi.org/10.1002/adhm.202300791
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.